Skip to content
This GLP
By This GLP Editorial Team · Updated September 2026A first-month price, once

The Edit review

The first month is priced below the standing rate for a limited time, and only once.

The verdict

The Edit publishes $259 a month for compounded semaglutide, with a limited-time first month at $200. Tirzepatide is $349 after a $300 first month. Fifty states are covered.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
Dose pricing
Flat across doses
States
50
From
From $259/mo
Prescription
Required
Compounded
Yes — not FDA-approved
Availability
All 50 states

The Edit sells both molecules by injection across fifty states, with prepay tiers billed once upfront and a limited-time first-month price.

  1. Who writes the prescription, and what do they see?

    A prescription precedes shipping. The pages state rates and tiers. The clinician is not described and the intake is not documented.

    A first-month price is a discount, not a rate. The figure a buyer meets first is not the one they will pay. The standing rate is published beside it, which is the part that matters.

  2. What happens when the dose goes up?

    Both lines are stated flat, so the rate holds as the dose rises. The prepay tiers are about term rather than dose, so neither variable is left unstated.

  3. What the price includes

    Six months of semaglutide at the standing rate is $1,554. Prepaying brings it to $575 for three months, about $192 a month, or $1,065 for six, about $178. Tirzepatide is $349 a month, or $855 and $1,575 prepaid, about $285 and $263 a month.

  4. What it claims, and what it cites

    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.

Where it holds up, and where it does not

  • Strength: The first-month price is labeled limited time
  • Strength: Standing rates published beside it
  • Strength: Prepay totals stated, not just rates
  • Strength: Coverage across all fifty states
  • Limitation: The first figure is a one-time discount
  • Limitation: Tirzepatide costs $90 more a month
  • Limitation: Prepaid tiers bill in one charge
  • Limitation: No compounding pharmacy is named

What the evidence says about this kind of treatment

The assessment above is about The Edit. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader who reads the standing rate beside the first-order figure.
Wrong for
A reader budgeting six months from the first-month figure.

The evidence behind what The Edit prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

How The Edit compares

SellerWho it suitsGo
TMatesReaders choosing between formats who do not want the choice pricedSee TMates →
TeleClinicReaders who want the standard rate stated beside the introductory one before they sign upSee TeleClinic →
Telos RxReaders taking the longest plan, since no shorter term carries a published rateSee Telos Rx →
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: Bionomy HealthBioverseBlis MDBlivBloom MDBloomWell Rx

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

Check SkinnyRx availability →

Frequently asked

Is $200 the ongoing price?
No. It is a limited-time first month. The standing rate is $259 a month.
What do the prepay tiers cost?
$575 for three months and $1,065 for six, billed once upfront, which is about $192 and $178 a month.
Does the price rise with the dose?
No. Both lines are stated flat across doses.
Is The Edit legit?
The Edit is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
Is The Edit expensive compared with other GLP-1 telehealth sellers?
The Edit publishes a starting figure of $259/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts The Edit above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
This GLP Editorial TeamPublisher · Updated September 2026

How this was assessed. The four questions above are answered from The Edit’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.